Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 716FQ5REVO

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Serine/threonine-protein kinase receptor R3 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Mesothelioma 2 D008654 ClinicalTrials
Carcinoma, Hepatocellular 2 D006528 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Colorectal Neoplasms 1 D015179 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109295
FDA SRS 716FQ5REVO